Prognostic and predictive value of a microRNA signature in adults with T-cell lymphoblastic lymphoma.
Leukemia
; 33(10): 2454-2465, 2019 10.
Article
em En
| MEDLINE
| ID: mdl-30953029
ABSTRACT
New prognostic factors are needed to establish indications for haematopoietic stem cell transplantation (HSCT) in first complete remission (CR1) for T-cell lymphoblastic lymphoma (T-LBL) patients. We used microarray to compare T-LBL tissue samples (n = 75) and fetal thymus tissues (n = 20), and identified 35 differentially expressed miRNAs. Using 107 subjects as the training group, we developed a five-miRNA-based classifier to predict patient survival with LASSO Cox regression lower risk was associated with better prognosis (disease-free survival (DFS) hazard ratio (HR) 4.548, 95% CI 2.433-8.499, p < 0.001; overall survival (OS) HR 5.030, 95% CI 2.407-10.513, p < 0.001). This classifier displayed good performance in the internal testing set (n = 106) and the independent external set (n = 304). High risk was associated with more favorable response to HSCT (DFS HR 1.675, 95% CI 1.127-2.488, p = 0.011; OS HR 1.602, 95% CI 1.055-2.433, p = 0.027). When combined with ECOG-PS and/or NOTCH1/FBXW7 status, this classifier had even better prognostic performance in patients receiving HSCT (DFS HR 2.088, 95% CI 1.290-3.379, p = 0.003; OS HR 1.996, 95% CI 1.203-3.311, p = 0.007). The five-miRNA classifier may be a useful prognostic biomarker for T-LBL adults, and could identify subjects who could benefit from HSCT.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Linfócitos T
/
MicroRNAs
/
Leucemia-Linfoma Linfoblástico de Células Precursoras
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article